The number of people affected by Parkinson disease has doubled over the past 25 years, and it is projected to double again in the next 25. With this rapid trajectory it is imperative that research meets the challenge to develop innovative and effective strategies to enhance the lives of Parkinson’s patients – with the goal of slowing down disease progression, understanding the causes of the disease, and finding better treatments.
In October 2018, the University of Rochester was designated as one of the Morris K. Udall Centers of Excellence in Parkinson’s Disease Research by the National Institute of Neurological Disorders and Stroke. The Centers of Excellence program was created to honor former Congressman Morris K. Udall of Arizona, who was diagnosed with Parkinson’s in 1979. In November 1997 the Morris K. Udall Parkinson’s Disease Research Act was signed into law, and the Centers of Excellence were established.
The UR-Udall Center is housed within the Center for Health + Technology (CHeT) at the University of Rochester Medical Center. Ray Dorsey, David M. Levy Professor of Neurology, serves as principal investigator. With expertise in technology research, predictive analytics, patient-reported outcome measures, trials coordination, and clinical materials services, CHeT is well positioned to accelerate Parkinson’s disease research through novel tools and technologies, disease modeling, and virtual visits. For more information on the Center for Health + Technology (CHeT), download our brochure.
Morris K. Udall, Arizona Congressman (1961-1991), died in 1998 after a 21-year battle with Parkinson’s disease (PD). To honor his lifetime dedicated to public service, advocacy, and stewardship, Congress established the Morris K. Udall, Centers of Excellence for Parkinson’s Disease Research that same year. Each Center takes a specific approach to innovative, interdisciplinary research to gain an enhanced understanding of the causes of and treatments for PD. Together, the Centers are committed to Morris K. Udall’s legacy of creativity and collaboration to advance breakthrough clinical treatments, methods of diagnosis, and novel tools and technologies as they continue to search for a cure.
Early Career Investigators
Awards & Accomplishments